Abramson F P, Jenkins J, Ostchega Y
Clin Pharmacol Ther. 1982 Nov;32(5):659-63. doi: 10.1038/clpt.1982.218.
The plasma concentrations of alpha 1-acid glycoprotein (AAG) and albumin, and the plasma protein binding of propranolol were measured in a group of cancer patients and a group of normal subjects. In cancer patients the AAG concentrations were twice that in controls (142 and 78 mg/dl, P less than 0.005), the albumin concentrations were lower (3.11 and 4.37 gm/dl, P less than 0.001), and the free fraction of propranolol was lower (0.127 and 0.190, P less than 0.005). Propranolol binding correlated strongly with AAG concentrations. These data imply that untreated or unsuccessfully treated cancer patients will have reduced free fractions for any drug for which AAG is an important binding protein. Successfully treated patients may have longitudinal changes towards normal. No consistent effect of the treatments themselves on AAG was observed after radiation therapy in five patients or after intravenous adriamycin in six patients.
对一组癌症患者和一组正常受试者测量了α1-酸性糖蛋白(AAG)和白蛋白的血浆浓度以及普萘洛尔的血浆蛋白结合率。癌症患者的AAG浓度是对照组的两倍(分别为142和78mg/dl,P<0.005),白蛋白浓度较低(分别为3.11和4.37g/dl,P<0.001),普萘洛尔的游离分数较低(分别为0.127和0.190,P<0.005)。普萘洛尔结合与AAG浓度密切相关。这些数据表明,未经治疗或治疗未成功的癌症患者,对于以AAG作为重要结合蛋白的任何药物,其游离分数都会降低。成功治疗的患者可能会向正常状态发生纵向变化。在5例患者接受放射治疗或6例患者接受静脉注射阿霉素后,未观察到治疗本身对AAG有一致的影响。